Sigle, A.; Jilg, C.A.; Kuru, T.H.; Binder, N.; Michaelis, J.; Grabbert, M.; Schultze-Seemann, W.; Miernik, A.; Gratzke, C.; Benndorf, M.;
et al. Evaluation of the Ginsburg Scheme: Where Is Significant Prostate Cancer Missed? Cancers 2021, 13, 2502.
https://doi.org/10.3390/cancers13102502
AMA Style
Sigle A, Jilg CA, Kuru TH, Binder N, Michaelis J, Grabbert M, Schultze-Seemann W, Miernik A, Gratzke C, Benndorf M,
et al. Evaluation of the Ginsburg Scheme: Where Is Significant Prostate Cancer Missed? Cancers. 2021; 13(10):2502.
https://doi.org/10.3390/cancers13102502
Chicago/Turabian Style
Sigle, August, Cordula A. Jilg, Timur H. Kuru, Nadine Binder, Jakob Michaelis, Markus Grabbert, Wolfgang Schultze-Seemann, Arkadiusz Miernik, Christian Gratzke, Matthias Benndorf,
and et al. 2021. "Evaluation of the Ginsburg Scheme: Where Is Significant Prostate Cancer Missed?" Cancers 13, no. 10: 2502.
https://doi.org/10.3390/cancers13102502
APA Style
Sigle, A., Jilg, C. A., Kuru, T. H., Binder, N., Michaelis, J., Grabbert, M., Schultze-Seemann, W., Miernik, A., Gratzke, C., Benndorf, M., & Suarez-Ibarrola, R.
(2021). Evaluation of the Ginsburg Scheme: Where Is Significant Prostate Cancer Missed? Cancers, 13(10), 2502.
https://doi.org/10.3390/cancers13102502
